GMAS Trademark

Trademark Overview

On Friday, April 17, 2015, a trademark application was filed for GMAS with the United States Patent and Trademark Office. The USPTO has given the GMAS trademark a serial number of 86601678. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 6, 2017. This trademark is owned by Emas Pharma Inc.. The GMAS trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, providing information management services; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Providing business management information in connection with consulting and advisory services in the field of strategic planning; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies

Conducting early evaluations in the field of new pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of clinical trials, pharmacovigilance, medical research information services, pharmaceutical and biotechnology product development; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Product development consulting in the field of pharmaceuticals and biotechnology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific study and research in the field(s) of pharmaceuticals and biotechnology
gmas

General Information

Serial Number86601678
Word MarkGMAS
Filing DateFriday, April 17, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 6, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2015

Trademark Statements

Goods and ServicesBusiness consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, providing information management services; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Providing business management information in connection with consulting and advisory services in the field of strategic planning; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies
Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of clinical trials, pharmacovigilance, medical research information services, pharmaceutical and biotechnology product development; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Product development consulting in the field of pharmaceuticals and biotechnology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific study and research in the field(s) of pharmaceuticals and biotechnology

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, April 28, 2015
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 28, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NameEmas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, February 6, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 6, 2017ABANDONMENT - NO USE STATEMENT FILED
Wednesday, June 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 13, 2016EXTENSION 1 GRANTED
Monday, June 13, 2016EXTENSION 1 FILED
Monday, June 13, 2016TEAS EXTENSION RECEIVED
Tuesday, January 5, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2015PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 6, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 5, 2015ASSIGNED TO LIE
Tuesday, September 8, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 8, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, September 8, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 8, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, September 8, 2015EXAMINERS AMENDMENT -WRITTEN
Monday, July 27, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 27, 2015NON-FINAL ACTION E-MAILED
Monday, July 27, 2015NON-FINAL ACTION WRITTEN
Monday, July 27, 2015ASSIGNED TO EXAMINER
Tuesday, April 28, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 21, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

gmas clinical research field services management pharmaceutical biotechnology trials consulting development